Polymorphs of dolutegravir and salts thereof
US10647729B1 · kind B1 · utility
0Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 14, 2020 |
| Grant date | May 12, 2020 |
| Priority date | — |
| Expiry date | Jan 14, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel crystalline forms of dolutegravir, process for its preparation and pharmaceutical composition comprising them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.